HB 1822

Abstract

Health insurance; cost-sharing payments for prescription asthma inhalers. Prohibits health insurance companies and other carriers from setting an amount exceeding $50 per 30-day supply of a tier one or tier two prescription asthma inhaler that a covered person is required to pay at the point of sale in order to receive a covered prescription asthma inhaler unless the carrier is prohibited from providing the additional benefits under state or federal law. The measure also prohibits a provider contract between a carrier or its pharmacy benefits manager and a pharmacy from containing a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription asthma inhaler in an amount that exceeds such limitation. The provisions apply with respect to health plans and provider contracts entered into, amended, extended, or renewed on or after January 1, 2022.

Health insurance; cost-sharing payments forprescription asthma inhalers. Prohibits health insurance companiesand other carriers from setting an amount exceeding $50 per prescriptionasthma inhaler that a covered person is required to pay at the pointof sale in order to receive a covered prescription asthma inhaler.The measure also prohibits a provider contract between a carrieror its pharmacy benefits manager and a pharmacy from containing aprovision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect,or (iii) requiring a covered person to make a cost-sharing paymentfor a covered prescription asthma inhaler in an amount that exceedssuch limitation. The provisions apply with respect to health plansand provider contracts entered into, amended, extended, or renewed on or after January 1, 2022.